Methadone Rapid Restart
A legfontosabb adatok
- Ki végzi
- Pouya Azar
- Hol
- Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toborzás még nem indult
- Fázis
- 4. fázis
- Résztvevők
- 25 fő, tervezett
- Kezdés
- 2026. máj.
- Várható befejezés
- 2027. márc.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Methadone
- A regiszteradat frissítve
- 2026. április 22.
Ki vehet részt
- Életkor
- 19 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 20 feltétel megnézéseKevesebb
Ki vehet részt
- Age 19 years or older
- Opioid use disorder (OUD) of any severity by DSM-5 TR Clinical Diagnostic criteria [American Psychiatric Association, 2022]
- Previously 'stable' on methadone as per the below definitions:; Previous maintenance treatment with methadone for opioid use disorder at a stable dose for at least 5 consecutive days prior to discontinuing, with allowance for a maximum of 1 missed dose within that 5-day period; Participants who were being titrated on methadone for opioid use disorder prior to discontinuation. If participants were on the most recent dose for less than 5 days, they can be restarted on the prior dose providing they cumulatively received 5 consecutive doses (with a maximum of 1 missed dose in that period) between the two most recent dosages
- Missed 4-8 doses of methadone in a row leading up to intake assessment
- Participant able to provide baseline opiate use history as per opiate use screening questions in Appendix A. This must provide an estimate of opiate use prior to stopping methadone and change in use since stopping
- Self-reported increased use of fentanyl since stopping methadone
- No significant change in opiate withdrawal symptoms as compared to when on methadone, based on self-report and examination
- Urine drug test (UDT) positive for fentanyl at screening or within 24 hours prior to re-initiating methadone
- Participant wishes to continue methadone maintenance treatment
- If applicable the participant must be willing to complete a urine pregnancy test to ensure they are not currently pregnant
- Participants will require a baseline ECG that demonstrates a QTc < 500ms
- For participants from VGH study site specifically:; must be admitted to either psychiatry or CTU, ideally with planned admission of at least 3 days; must agree if discharged prior to the completion of the 7 day follow up period, to either return to VGH Diamond Centre for follow up assessments on Days 1/3/7 (+/-2 days); must have access to a functioning cell phone to allow for the study team to contact them in case of discharge prior to completion of study follow up period
- The participants must be willing and able to provide written informed consent for study participation
Ki nem vehet részt
- Self-reported Opioid overdose or naloxone administration since methadone discontinuation or during the 5 days prior to methadone discontinuation
- Use of buprenorphine-naloxone (Suboxone®, Sublocade®, Butrans ®) within the previous 3 days (self-reported)
- Self-reported New cardiac disease diagnosis since methadone discontinuation
- Participants with a QTc interval >500 msec on the screening ECG
- COWS score of 8 or more at the time of clinician assessment
- Self-reported Intolerable side effects reported when taking methadone
- Individuals who are pregnant (urine pregnancy test) or breast-feeding (self-reported)
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The usual treatment for opioid use disorder (OUD) is opioid agonist therapy (OAT) with either methadone or buprenorphine. These treatments are well-established, reduce the risk of fatal overdoses, and are considered the standard approach. However, current methadone guidelines were developed when most people were using heroin, which is far less potent than today's unregulated/illicit fentanyl supply. As a result, people who use fentanyl often need higher doses to feel stable. Because methadone must be started at low doses and increased slowly, it can take weeks before someone reaches an effective dose. This process becomes even longer when doses are missed, since treatment often needs to be restarted at a lower level.
A teljes eredeti leírásKevesebb
The Methadone Rapid Restart is a newer strategy designed to take ongoing fentanyl use into account. Early clinical experience and modelling suggest that many people who use fentanyl have high opioid tolerance and may be able to return to their previous stable methadone dose even after several missed days, without added safety risk. This approach has shown promise in small clinical settings, but it is not yet known whether it provides better outcomes than the standard methadone titration used today. This study will be testing whether this protocol to help rapidly restart people on Methadone is acceptable for patients and use the learning to guide a subsequent larger clinical trial.
A vizsgálat 2 csoportja
- Methadone rapid restart for participants on methadone maintenance treatmentA vizsgált kezelés
Participants who have missed 4-8 doses of methadone, but were on maintenance treatment with methadone for opioid use disorder at a stable dose for at least 5 consecutive days prior to discontinuing, with allowance for a maximum of 1 missed dose within that 5-day period. These participants will be re-initiated on 100% of their most recent methadone dose.
Kezelés: Methadone
- Methadone rapid restart for participants being titrated on methadoneA vizsgált kezelés
Participants who have missed 4-8 doses of methadone, but were being titrated on methadone prior to discontinuation such that they were on their most recent dosage for less than 5 days but received at least 5 consecutive days of methadone between the prior two dosages (with a maximum of 1 missed dose in that period) be. These participants will be restarted on the lower of their two most recent dosages.
Kezelés: Methadone
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Methadone Rapid Restart Study
- A regiszteradat frissítve
- 2026. április 22.